Interim Dividend: A famous pharma company declared an interim dividend of 250 per cent for financial year 2025-26. Besides, the company has also fixed
the dividend record date and payment date (credit date). The pharma company under discussion is a constituent of BSE 500 index. The name of stock is Glenmark Pharmaceuticals.
Glenmark Pharma Dividend 2025 Announcement
In an exchange dated September 26, Glenmark Pharmaceuticals said that the board has recommended an interim dividend of 250 per cent or Rs 2.50 per share of Re 1 face value.
"The Board of Directors of the Company, has considered and approved the Interim Dividend of Rs 2.50 per equity shares on face value of Re 1 per equity shares for the Financial Year 2025-26 amounting to Rs 705.50 millions," Glenmark Pharma said in filing.
Glenmark Pharma Dividend 2025 Record Date, Credit Date
Glenmark Pharma said that October 3 will be considered as the dividend record date while the dividend will be paid to eligible shareholders within 30 days from the date of the declaration.
"As intimated earlier on 22nd September 2025, the record date for the purpose of payment of dividend shall be Friday, 3rd October, 2025, and the interim dividend will be paid within 30 days from the date of the declaration," Glenmark Pharma added.
Glenmark Pharma Share Price
Glenmark Pharma is a leading global pharmaceutical company with a strong presence in the branded, generics and OTC (Over-the-Counter) segments.
Glenmark Pharma shares traded 2.50 per cent lower at Rs 1980.55 on BSE around 11:30 AM on Friday (September 26).
Glenmark Pharma Dividend History
This is the first interim dividend announcement by Glenmark Pharmaceuticals after five final dividend -- 2021, 2022, 2023, 2024 and 2025.
According to BSE data, Glenmark Pharma has consistently paid 250 per cent or Rs 2.50 dividend once every year since 2020 (2020 -- interim, 2021, 2022, 2023, 2024 and 2025).
Glenmark Pharma Share Price History
Glenmark Pharma shares have delivered a solid return of 35 per cent in six months. In one year, the pharma counter has surged 18 per cent. In two and three years, the pharma stock has delivered a huge return of 160 per cent and 435 per cent.
Glenmark Pharma shares have a 52-week range of Rs 2,286.15 - Rs 1,274.70 on NSE. The pharma company commands a market cap of Rs 55,858 crore.
(Disclaimer: The above article is meant for informational purposes only, and should not be considered as any investment advice. ET NOW DIGITAL suggests its readers/audience to consult their financial advisors before making any money related decisions.)
